Genotyping of IL-8-251 T > A yields prognostic information in patients with gastric carcinoma

References

• Ahmed OI, Adel AM, Diab DR, Gobran NS. (2006). Prognostic value of serum level of interleukin-6 and interleukin-8 in metastatic breast cancer patients. Egypt J Immunol 13:61–8
   Google Scholar
• Bell CG. (2011). Accessing and selecting genetic markers from available resources. Methods Mol Biol (Clifton, NJ) 760:1–17
   Google Scholar
• Benoy IH, Salgado R, Van Dam P, et al. (2004). Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10:7157–62
   PubMed Web of Science ®Google Scholar
• Canas M, Moran Y, Rivero M, et al. (2009). Interleukin-1 genetic polymorphism: association with gastric cancer in the high-risk Central-Western population of Venezuela. Rev Med Chile 137:63
   Google Scholar
• Canedo P, Castanheira-Vale AJ, Lunet N, et al. (2008). The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev 17:28–32
   Google Scholar
• Caruso DJ, Carmack AJ, Lokeshwar VB, et al. (2008). Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence. Clin Cancer Res 14:4111–18
   Google Scholar
• Derin D, Soydinc HO, Guney N, et al. (2007). Serum IL-8 and IL-12 levels in breast cancer. Med Oncol 24:163–8
   PubMedGoogle Scholar
• Donn R, Alourfi Z, De Benedetti F, et al. (2002). Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 46:2402–9
   PubMed Web of Science ®Google Scholar
• Freund A, Chauveau C, Brouillet JP, et al. (2003). IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene 22:256–5
   PubMed Web of Science ®Google Scholar
• Gao LB, Rao L, Wang YY, et al. (2009). The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis 30:295–9
   PubMed Web of Science ®Google Scholar
• Graziano F, Ruzzo A, Santini D, et al. (2005). Prognostic role of interleukin-1β gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol 23:2339–45
   PubMed Web of Science ®Google Scholar
• He BS, Pan YQ, Xu YF, et al. (2011). Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci 56:2017–23
   Google Scholar
• Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. Cancer J Clin 61:69–90
   PubMed Web of Science ®Google Scholar
• Kang JM, Kim N, Lee DH, et al. (2009). The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol 43:420–8
   PubMed Web of Science ®Google Scholar
• Kassim SK, El-Salahy EM, Fayed ST, et al. (2004). Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem 37:363–9
   PubMed Web of Science ®Google Scholar
• Kido S, Kitadai Y, Hattori N, et al. (2001). Interleukin 8 and vascular endothelial growth factor – prognostic factors in human gastric carcinomas? Eur J Cancer 37:1482–7
   PubMed Web of Science ®Google Scholar
• Kitadai Y, Haruma K, Sumii K, et al. (1998). Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 152:93–100
   PubMed Web of Science ®Google Scholar
• Kitadai Y, Takahashi Y, Haruma K, et al. (1999). Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 81:647–53
   PubMed Web of Science ®Google Scholar
• Kocak H, Oner-Iyidogan Y, Kocak T, Oner P. (2004). Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer. Clin Biochem 37:673–8
   PubMed Web of Science ®Google Scholar
• Konno H, Ohta M, Baba M, et al. (2003). The role of circulating IL-8 and VEGF protein in the progression of gastric cancer. Cancer Sci 94:735–40
   PubMed Web of Science ®Google Scholar
• Lakhani SR, Ashworth A. (2001). Microarray and histopathological analysis of tumours: the future and the past? Nat Rev Cancer 1:151–7
   PubMed Web of Science ®Google Scholar
• Lee HL, Eom HS, Yun T, et al. (2008). Serum and urine levels of interleukin-8 in patients with non-Hodgkin’s lymphoma. Cytokine 43:71–5
   Google Scholar
• Lee JY, Kim HY, Kim KH, et al. (2005). Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 225:207–14
   Google Scholar
• Lee KH, Bae SH, Lee JL, et al. (2004). Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. Oncology 66:210–17
   Google Scholar
• Li C, Xia HHX, Xie W, et al. (2007). Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population. J Gastroenterol Hepatol 22:234–9
   PubMedGoogle Scholar
• Liu L, Zhuang W, Wang C, et al. (2010). Interleukin-8-251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. Cytokine 50:328–34
   Google Scholar
• Lu W, Pan K, Zhang L, et al. (2005). Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population. Carcinogenesis 26:631–6
   PubMed Web of Science ®Google Scholar
• Lurje G, Husain H, Power DG, et al. (2010). Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann Oncol 21:78–86
   PubMed Web of Science ®Google Scholar
• Lurje G, Zhang W, Schultheis AM, et al. (2008). Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 19:1734–41
   PubMed Web of Science ®Google Scholar
• Macri A, Versaci A, Loddo S, et al. (2006). Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers 11:184–93
   PubMed Web of Science ®Google Scholar
• Maeda S, Otsuka M, Hirata Y, et al. (2001). cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. Biochem Biophys Res Commun 284:443–9
   PubMed Web of Science ®Google Scholar
• Merritt WM, Lin YG, Spannuth WA, et al. (2008). Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst 100:359–72
   PubMed Web of Science ®Google Scholar
• Nastase A, Paslaru L, Niculescu AM, et al. (2011). Prognostic and predictive potential molecular biomarkers in colon cancer. Chirurgia 106:177–85
   Google Scholar
• Ning Y, Manegold PC, Hong YK, et al. (2011). Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer 128:2038–49
   PubMed Web of Science ®Google Scholar
• Ohyauchi M, Imatani A, Yonechi M, et al. (2005). The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54:330–5
   PubMed Web of Science ®Google Scholar
• Pavel ME, Hassler G, Baum U, et al. (2005). Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas. Clin Endocrinol 62:434–43
   PubMed Web of Science ®Google Scholar
• Persson C, Engstrand L, Nyrén O, et al. (2009). Interleukin 1-β gene polymorphisms and risk of gastric cancer in Sweden. Scand J Gastroenterol 44:339–45
   PubMed Web of Science ®Google Scholar
• Rae JM, Cordero KE, Scheys JO, et al. (2003). Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. Pharmacogenetics 13:501–7
   Google Scholar
• Ren Y, Poon RT, Tsui HT, et al. (2003). Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 9:5996–6001
   PubMed Web of Science ®Google Scholar
• Sadlecki P, Walentowicz-Sadlecka M, Szymanski W, Grabiec M. (2011). Comparison of VEGF, IL-8 and beta-FGF concentrations in the serum and ascites of patients with ovarian cancer. Ginekol Pol 82:498–502
   PubMed Web of Science ®Google Scholar
• Schultheis AM, Lurje G, Rhodes KE, et al. (2008). Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res 14:7554–63
   PubMed Web of Science ®Google Scholar
• Shin WG, Jang JS, Kim HS, et al. (2008). Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. J Gastroenterol Hepatol 23:1567–73
   Google Scholar
• Smith KC, Bateman AC, Fussell HM, Howell WM. (2004). Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 31:167–73
   PubMedGoogle Scholar
• Snoussi K, Mahfoudh W, Bouaouina N, et al. (2006). Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 67:13–21
   PubMedGoogle Scholar
• Song JH, Kim SG, Jung SA, et al. (2010). The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans. Cytokine 51:158–65
   Web of Science ®Google Scholar
• Sugimoto M, Furuta T, Shirai N, et al. (2007). Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 22:1443–9
   PubMed Web of Science ®Google Scholar
• Taguchi A, Ohmiya N, Shirai K, et al. (2005). Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 14:2487–93
   PubMed Web of Science ®Google Scholar
• Terada H, Urano T, Konno H. (2005). Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer. Eur Surg Res 37:166–72
   PubMed Web of Science ®Google Scholar
• Vinagre RM, Corvelo TC, Arnaud VC, et al. (2011). Determination of strains of Helicobacter pylori and of polymorphism in the interleukin-8 gene in patients with stomach cancer. Arq Gastroenterol 48:46–51
   Google Scholar
• Wang J, Pan HF, Hu YT, et al. (2010). Polymorphism of IL-8 in 251 allele and gastric cancer susceptibility: a meta-analysis. Dig Dis Sci 55:1818–23
   Web of Science ®Google Scholar
• Wang N, Zhou R, Wang C, et al. (2012). -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep 39:2831–41
   PubMed Web of Science ®Google Scholar
• Wang P, Xia HHX, Zhang JY, et al. (2006). Association of interleukin-1 gene polymorphisms with gastric cancer: A meta-analysis. Int J Cancer 120:552–62
   Google Scholar
• Xue H, Lin B, Ni P, et al. (2010). Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol 25:1604–17
   PubMed Web of Science ®Google Scholar
• Ye BD, Kim SG, Park JH, et al. (2009). The interleukin-8-251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans. J Clin Gastroenterol 43:233–9
   Web of Science ®Google Scholar
• Yu J, Zeng Z, Wang S, et al. (2010). IL-1B-511 polymorphism is associated with increased risk of certain subtypes of gastric cancer in Chinese: a case-control study. Am J Gastroenterol 105:557–64
   PubMed Web of Science ®Google Scholar
• Yuzhalin A. (2011). The role of interleukin DNA polymorphisms in gastric cancer. Human Immunol 72:1128–36
   PubMed Web of Science ®Google Scholar
• Zhang H, Fu T, McGettigan S, et al. (2011). IL8 and cathepsin B as melanoma serum biomarkers. Int J Mol Sci 12:1505–18
   Google Scholar
• Zhang L, Du C, Guo X, et al. (2010). Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China. Mol Biol Rep 37:3983–9
   PubMed Web of Science ®Google Scholar
• Zhou Y, Hu W, Zhuang W, Wu X. (2011). Interleukin-10 -1082 promoter polymorphism and gastric cancer risk in a Chinese Han population. Mol Cell Biochem 347:89–93
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang J, He Q, Zhang JQ. (2011). The association between interleukin-10-592 polymorphism and gastric cancer risk: a meta-analysis. Med Oncol 28:133–6
   Google Scholar